Search - tctmd.com

Displaying 761 - 780 of 1213

Sort: Relevancy | Date

News Conference News ISC 2019

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

Todd Neale

February 08, 2019

Presentation ISC 2019

Telerehabilitation In The Home Versus Therapy In-Clinic For Patients With Stroke

Presenter: Steven C. Cramer

February 08, 2019

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Caitlin E. Cox

February 08, 2019

News Conference News ISET 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Caitlin E. Cox

February 07, 2019

News Conference News ISC 2019

Mechanical Thrombectomy Outcomes May Be Worse at Low-Volume Stroke Centers

Todd Neale

February 07, 2019

News Conference News ISET 2019

Acute PE Algorithm in the Works to Guide Clinicians’ Complex Decision-making

Caitlin E. Cox

February 05, 2019

News Conference News ISET 2019

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Caitlin E. Cox

January 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Conference News ISET 2019

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Caitlin E. Cox

January 30, 2019

Presentation ISET 2019

Case-Based Tibial Arterial Disease

Presenter: Alex Powell

January 30, 2019

Presentation ISET 2019

Can Chelation Therapy Benefit Patients with Critical Limb Ischemia?

Presenter: Gervasio A. Lamas

January 30, 2019

Presentation ISET 2019

Evaluating the CLI Patient: What Testing Options Are there?

Presenter: Nicos Labropoulos

January 30, 2019

News Conference News ISET 2019

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Caitlin E. Cox

January 29, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

News Conference News ISET 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Caitlin E. Cox

January 28, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Shelley Wood

January 21, 2019

News Daily News

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Michael O'Riordan

January 17, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

Advertisement

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

Telerehabilitation In The Home Versus Therapy In-Clinic For Patients With Stroke

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Mechanical Thrombectomy Outcomes May Be Worse at Low-Volume Stroke Centers

Acute PE Algorithm in the Works to Guide Clinicians’ Complex Decision-making

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

TCTMD’s Top 10 Most Popular Stories for January 2019

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Case-Based Tibial Arterial Disease

Can Chelation Therapy Benefit Patients with Critical Limb Ischemia?

Evaluating the CLI Patient: What Testing Options Are there?

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content